Pulse Biosciences (NASDAQ:PLSE – Get Free Report) will be posting its quarterly earnings results after the market closes on Tuesday, May 7th. Investors that are interested in registering for the company’s conference call can do so using this link.
Pulse Biosciences (NASDAQ:PLSE – Get Free Report) last announced its earnings results on Thursday, March 28th. The company reported ($0.21) earnings per share (EPS) for the quarter.
Pulse Biosciences Price Performance
PLSE stock traded up $0.19 on Tuesday, reaching $7.44. 27,953 shares of the company were exchanged, compared to its average volume of 177,623. Pulse Biosciences has a 12 month low of $3.78 and a 12 month high of $13.62. The stock’s fifty day moving average price is $8.66 and its 200 day moving average price is $8.25. The firm has a market capitalization of $410.84 million, a PE ratio of -8.15 and a beta of 1.67.
Pulse Biosciences Company Profile
Pulse Biosciences, Inc operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology.
Featured Articles
- Five stocks we like better than Pulse Biosciences
- How to Calculate Options Profits
- NXP Semiconductors Will Set a New High Soon: $300 in Sight
- Energy and Oil Stocks Explained
- Hilton Demonstrates Asset Light is Right for Investors
- 3 Fintech Stocks With Good 2021 Prospects
- Boston Scientific Bucks the Medtech Slow Down and Raises Outlook
Receive News & Ratings for Pulse Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pulse Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
